Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

European approval recommended for Lysodren

Jan. 27, 2004

CPMP recommends extension of Paxene indications

Jan. 27, 2004

CR-4: a novel tyrosine kinase inhibitor active against ALL and AML cell lines

Jan. 27, 2004

Onyvax and Mayo Clinic to develop cancer vaccines for ovarian cancer

Jan. 26, 2004

Zevalin radioimmunotherapy receives European approval

Jan. 26, 2004

CytoGenix and Baylor to test aerosol gene silencing agent on mouse lung cancer

Jan. 23, 2004

OSI commences rolling NDA submission for Tarceva for NSCLC

Jan. 23, 2004

PI-88 enters phase II melanoma trial

Jan. 23, 2004

Tubercin shows activity in mouse metastatic melanoma

Jan. 23, 2004

Mercian and Eisai present novel VEGF production inhibitors for cancer therapy

Jan. 23, 2004

Popular Stories

Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
Innervation can slow, as well as speed, tumor growth, study finds
BioWorld
Innervation by the sympathetic nervous system is typically a boon to tumors. But researchers from Weill Cornell Medicine and colleagues have shown that in some...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...